Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dorothea Appelt

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Vaccines|March 30, 2023
Is There a Difference in Immune Response to SARS-CoV-2 Vaccination between Liver and Lung Transplant Patients with Cystic Fibrosis?Teresa Fuchs, Dorothea Appelt, Helmut Ellemunter
Chest|May 8, 2022
Cancer in Cystic Fibrosis: Do Not Neglect Gynecologic CancersDorothea Appelt, Gratiana Steinkamp, Helmut Ellemunter
Vaccines|January 22, 2024
Long-Term Assessment of Antibody Response to COVID-19 Vaccination in People with Cystic Fibrosis and Solid Organ TransplantationTeresa Fuchs, Dorothea Appelt, Helmut Ellemunter
Journal of Medical Case Reports|January 19, 2022
Malignancies in patients with cystic fibrosis: a case seriesDorothea Appelt, Teresa Fuchs, Gratiana Steinkamp, et al.
Clinical Case Reports|February 14, 2022
REAL-world clinical effectiveness of ivacaftor therapy in the first 24 months in two infants with cystic fibrosis and different gating mutations-A case reportTeresa Fuchs, Dorothea Appelt, Katharina Niedermayr, et al.
Frontiers in Pharmacology|March 27, 2023
Early and sustained improvements of lung clearance index from two to sixteen weeks of elexacaftor/tezacaftor/ivacaftor therapy in patients with cystic fibrosis-a real world studyDorothea Appelt, Gratiana Steinkamp, Sarah Sieber, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|January 29, 2025
Monitoring ETI effects over 1.7 years in an infant treated in utero, via breast milk and granules by repeated faecal elastase measurementsDorothea Appelt, Teresa Fuchs, Johannes Eder, et al.
Therapeutic Advances in Chronic Disease|August 12, 2022
Personalized medicine with drugs targeting the underlying protein defect in cystic fibrosis: is monitoring of treatment response necessary?Katharina Niedermayr, Verena Gasser, Claudia Rueckes-Nilges, et al.
BMC Pulmonary Medicine|June 18, 2024
Detection of cytokines in nasal lavage samples of patients with cystic fibrosis: comparison of two different cytokine detection assaysTeresa Fuchs, Manuela Zlamy, Thomas Zöggeler, et al.
International Journal of Molecular Sciences|October 26, 2024
Cytokines Measured in Nasal Lavage Compared to Induced Sputum in Patients with Mild Cystic FibrosisTeresa Fuchs, Artemis Vasiliadis, Manuela Zlamy, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Vaccines|March 30, 2023
Is There a Difference in Immune Response to SARS-CoV-2 Vaccination between Liver and Lung Transplant Patients with Cystic Fibrosis?Teresa Fuchs, Dorothea Appelt, Helmut Ellemunter
Chest|May 8, 2022
Cancer in Cystic Fibrosis: Do Not Neglect Gynecologic CancersDorothea Appelt, Gratiana Steinkamp, Helmut Ellemunter
Vaccines|January 22, 2024
Long-Term Assessment of Antibody Response to COVID-19 Vaccination in People with Cystic Fibrosis and Solid Organ TransplantationTeresa Fuchs, Dorothea Appelt, Helmut Ellemunter
Journal of Medical Case Reports|January 19, 2022
Malignancies in patients with cystic fibrosis: a case seriesDorothea Appelt, Teresa Fuchs, Gratiana Steinkamp, et al.
Clinical Case Reports|February 14, 2022
REAL-world clinical effectiveness of ivacaftor therapy in the first 24 months in two infants with cystic fibrosis and different gating mutations-A case reportTeresa Fuchs, Dorothea Appelt, Katharina Niedermayr, et al.
Frontiers in Pharmacology|March 27, 2023
Early and sustained improvements of lung clearance index from two to sixteen weeks of elexacaftor/tezacaftor/ivacaftor therapy in patients with cystic fibrosis-a real world studyDorothea Appelt, Gratiana Steinkamp, Sarah Sieber, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|January 29, 2025
Monitoring ETI effects over 1.7 years in an infant treated in utero, via breast milk and granules by repeated faecal elastase measurementsDorothea Appelt, Teresa Fuchs, Johannes Eder, et al.
Therapeutic Advances in Chronic Disease|August 12, 2022
Personalized medicine with drugs targeting the underlying protein defect in cystic fibrosis: is monitoring of treatment response necessary?Katharina Niedermayr, Verena Gasser, Claudia Rueckes-Nilges, et al.
BMC Pulmonary Medicine|June 18, 2024
Detection of cytokines in nasal lavage samples of patients with cystic fibrosis: comparison of two different cytokine detection assaysTeresa Fuchs, Manuela Zlamy, Thomas Zöggeler, et al.
International Journal of Molecular Sciences|October 26, 2024
Cytokines Measured in Nasal Lavage Compared to Induced Sputum in Patients with Mild Cystic FibrosisTeresa Fuchs, Artemis Vasiliadis, Manuela Zlamy, et al.
Pageof 2